Pacira Biosciences, Inc. (PCRX)
24.51
-0.85
(-3.35%)
USD |
NASDAQ |
Apr 24, 16:00
24.50
-0.01
(-0.04%)
After-Hours: 20:00
Pacira Biosciences EPS Diluted (Quarterly) : 0.0381 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Stryker Corp. | 2.197 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1341 |
| BioMarin Pharmaceutical, Inc. | -0.2423 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 1.637M |
| Revenue (Quarterly) | 196.87M |
| Total Expenses (Quarterly) | 195.24M |
| Enterprise Value | 1.172B |
| Gross Profit Margin (Quarterly) | 72.26% |
| Profit Margin (Quarterly) | 0.83% |
| Earnings Yield | 0.64% |
| Operating Earnings Yield | 3.06% |
| Normalized Earnings Yield | 1.616 |